ClinChoice
John Balian, MD, is an accomplished healthcare executive with extensive experience in various leadership roles within the pharmaceutical and consulting sectors. As the Chief Executive Officer of ClinChoice Inc since January 2018 and the Founder of MediVista Consulting, LLC since March 2016, John Balian has demonstrated expertise in management consulting. Previous positions include Chief Operating Officer and Chief Medical Officer at Johnson & Johnson, where responsibilities encompassed global regulatory affairs and clinical research, and Senior Vice President roles at Pfizer Inc and Bristol-Myers Squibb, focusing on safety and regulatory operations. Early career experience includes serving as Associate Director at the USFDA. John Balian holds an MD from Tufts University School of Medicine and a BA from Columbia University.
This person is not in any offices
ClinChoice
2 followers
ClinChoice is a full-service global clinical CRO dedicated to offering high-quality, efficient and flexible solutions to pharmaceutical, biotechnology, medical device, and consumer products clients worldwide. With a 25 year history of success, ClinChoice continues to be The Standard of Excellence for biostatistics, clinical operations, data management, statistical programming, CDISC, regulatory affairs, medical affairs and pharmacovigilance. ClinChoice has established major delivery centers across US, China, Europe, Canada, India, Japan and the Philippines. It has over 4,000 employees globally, with a strong and talented team, and a growing clinical operations presence in seven countries across Asia, North America and Europe.